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ABSTRACT
 
•
 
Behavioral experiments examined the role of morphiceptin in male rat copulatory 
behavior. Male copulatory behavior was recorded subsequent to bilateral injections of 
either 10, 500, or 1000 ng of morphiceptin into the medial preoptic area (MPOA) in 
sexually vigorous male rats. In the first experiment, all three doses of morphiceptin 
injected bilaterally into the MPOA produced a dramatic delay in the initiation of copulation. 
Both mount and intromission latencies significantly increased following injections of all 
three doses of morphiceptin when compared to saline injected controls. No other 
tJ­
parameter was effected. In experiment 2, the inhibitory effects of morphiceptin on male 
copulatory behavior were abolished by pretreatment with naloxone 20 minutes prior to 
intracerebral morphiceptin injections. This study represents an attempt at a 
pharmacological characterization of the inhibitory effects of opioids on male rat sexual 
behavior. The results of experiment 1 indicate that mu receptors located within the MPOA 
mediate the initiation of male rat copulatory behavior. 
GENERAL INTRODUCTION
 
•
 
A richly interconnected, sexually dimorphic circuit which includes the medial 
amygdala (MA), the bed nucleus of the stria terminalis (BnST), and the medial preoptic 
area (MPOA) has been reported to be an important pathway for the expression of male 
sexual behavior in rodents (see (9) for review). In particular, lesions of the MPOA have 
been reported to severely impair copulation and even to eliminate sexual behavior 
completely in a wide range of species (1,4,12,29,35); while electrical stimulation of the 
MPOA enhances the expr~ssion of male copulatory behavior (17,19). The dramatic 
effects on male copulatory behavior following lesions or electrical stimulation of the MPOA 
as compared to other brain structures, imply that the MPOA plays a central role in 
regulating male sexual behavior in the laboratory rat (see (31) for review). 
Although the importance of this interconnected circuit for male rat sexual behavior 
has been clearly demonstrated, one of the fundamental questions that remains to be 
answered is the identity of the neurotransmitter(s) within the circuit that regulates male 
copulatory behavior. Recently, experimental interest has focused on the idea that 
neuropeptides within the sexually dimorphic circuit play an important role in the regulation 
of male sexual behavior (7,8,33,34), (see (9) for review). One class of neuropeptide which 
is found in this circLiit is the opioid peptide. Indeed, there is a wealth of information which 
s 
reveals that the administration of opioid agonists inhibit sexual behavior in mammals, non­
t1 
human primates and humans (13,18,32), see (27) for review). 
One opioid of particular interest is beta-endorphin. Meyerson and Terenius 
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reported that three different doses (1, 3 and 30 micrograms) of beta-endorphin injected 
into the lateral ventricles (ICV) produced a dose-dependent inhibition of copulatory 
behavior in male rats. This effect was blocked by peripheral injections of naltrexone 30 
minutes before ICV injections of beta-endorphin (21). In a subsequent study, Meyerson 
again reported an inhibition of copulatory behavior following injections of beta-endorphin 
at lower doses (0.5 and 1.0 micrograms) into the cerebral ventricles. Interestingly, he also 
reported that although morphine, another opioid, had similar effects on copulatory 
behavior as beta-endorphin, morphine was not specific in that it suppressed a number of 
behaviors that beta-endorphin did not (20). 
It is surprising that until 1987 no published reports existed in the literature on the 
effects of opioid agonists on male sexual behavior following injections directly into brain 
loci implicated in male sexual behavior. Hughes et al. (14) were the first to examine the 
effects of injections of beta-endorphin into the sexually dimorphic circuit. Bilateral 
injections of beta-endorphin into the MPOA in male rats produced a dose-dependent 
inhibition of male copulatory behavior: mount, intromission and ejaculation latencies 
increased while the mount rates (mounts/min) decreased. In order to assess the 
anatomical specificity of action of beta-endorphin on male sexual behavior, in that same 
study beta-endorphin was also injected into the Bnst, another area implicated in male 
sexual behavior and located near the MPOA. Identical doses of beta-endorphin which 
produced a profound inhibition of male copulatory behavior in the MPOA, had no effect 
following bilateral injections into the BnST (14). 
Recently, there has been much speculation in the literature about the possible 
involvement of different opioid receptors in the regulation of male copulatol)' behavior. 
•
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The impetus for this has been derived from studies which have reported that selective 
activation of different opioid receptors have differential effects on sexual receptivity in 
ovariectomized-estrogen primed female rats. It appears that activation of high affinity mu 
receptors inhibit sexual receptivity, whereas mUz or delta receptor activation produce an 
inhibition (26,28). Based on such findings on female sexual behavior, studies have 
expanded to examine the behavioral effects of differential opioid receptor activation on 
copulatory behavior in male rats. Indeed, although opioid agonists have long been 
recognized as playing a predominantly inhibitory role in male sexual behavior, this dogma 
has recently been challenged. Band and Hull reported that unilateral injections of low 
doses of morphine (a relatively selective mu agonist) and dynorphin (a kappa agonist) into 
the MPOA of male rats produced a facilitation in copulatory behavior at 10-100 pmol. 
Males injected with a higher dose of morphine (6 nmol), however, showed an inhibition 
in copulatory behavior by failing to intromit after the second ejaculation. Band and Hull 
postulated that the different effects of morphine on male sexual behavior could be 
attributed to mUltiple receptor subtype activation (2). Indeed, morphine is only 50 times 
't\. 
more potent at mu receptors that at delta receptors (23). Given the relative lack of 
specificity of morphine for individual opioid receptor subtypes, it is possible that the 
differential effects of morphine could be attributed to activation of different opioid receptor 
subtypes. 
Therefore, a crucial step in assessing the role of opioids on male copulatory 
behavior is to elucidate the receptor subtype involved. Presently, however, it is not clear 
which receptor type mediates the inhibition of male copulatory behavior following central 
administration of opioid agonist. For example, beta-endorphin displays equal affinity to • 
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mu and delta receptors (16). Consequently, it is impossible to assess based on the 
results of the Hughes et al study which opioid receptor type located within the MPOA 
mediates the inhibition of male copulatory behavior. In contrast, morphiceptin is 
considered a selective opioid receptor agonist with a 1000 times greater affinity for mu 
than delta or kappa receptors (5,6). Therefore, in the present study, I assessed the role 
of mu receptors in male copulatory behavior following bilateral injections of morphiceptin 
into the MPOA. 
5 
GENERAL METHODS 
Animals and Surgery: 
•
 
Thirty adult male Long-Evan rats purchased from Charles River, Wilmington, MA, 
were used. The animals weighed between 375 and 450 grams. The rats were housed 
individually and maintained in a controlled environment on a light/dark cycle (lights on at 
6:00 and off at 21 :00). Animals were handled on a regular basis to minimize stress during 
intercerebral injections. Food and water were available ad lib throughout the experiment. 
Stimulus females of the same strain were ovariectomized under ether. Fifty-three hours 
and 4 hours before each behavioral test, females were injected subcutaneously with 10 
micrograms of estradiol benzoate and 1 microgram progesterone respectively, to ensure 
maximal sexual receptivity. Each male was given preoperative screening tests in which 
it was placed with a fully receptive female until one ejaculation was achieved. Only males 
that had ejaculated at least twice during the screening tests were subsequently used. 
Following the second or third successful preoperative test session, each male was 
anesthetized with Somnotol (50mg/kg) and received a pair of stereotaxically implanted 22­
gauge stainless steel guide cannulae, aimed 2mm above the medial preoptic area (MPOA) 
(from bregma, AP = +2/2; ML = -D.5; and DV = -6.3) using the atlas of Paxinos and 
Watson as a guide (24). The cannulae were secured with cranioplastic cement. 
1 
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Behavioral Testing: 
One week following the surgery the males were given a postoperative test in 
rectangular test arenas (20 x 15 x 14 in.) with standard bedding to obtain baseline 
measures. Ovariectomized, steroid-primed female rats were placed in the arena with the 
male rat. If a male failed to mount or intromit within the first five minutes of the baseline 
test, he was given another baseline test one week later. Those that failed the second 
baseline test were excluded from this study. 
All males that successfully completed a baseline test received injections of saline 
or morphiceptin seven days later. During experimental and baseline tests several 
measures were taken: mount latency (ML), the interval from the introduction of the female 
to the first mount by the male; intromission latency (IL), the interval from the introduction 
to the first intromission; the ejaculation latency (EL), the interval from the first intromission 
to the first ejaculation; the post-ejaculatory interval (PEl), the interval from the first 
ejaculation to the next mount; the mount frequency (MF), the number of mounts without 
intromission between the introduction and the ejaculation; the intromission frequency (IF), 
the number of intromissions between the introduction and the ejaculation; and the number 
of crawls exhibited. The last measure was taken to provide another measure of sexual 
motivation beside mount latency. The test period lasted either 30 minutes or until the first 
mount following ejaculation (PEl). The intercopulatory interval (lei), mean interval between 
intromissions, was also obtained by dividing the overall ejaculation latency by the 
intromission frequency. Animals that failed to mount, intromit or ejaculate during the 
morphiceptin testing were assigned latencies of 900 second, the duration of the 
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observation period (14). 
Intracerebral Injections: 
Rats were taken from their cages and individually placed on a table in a low light, 
low noise situation. The 26 gauge inner cannula (extending 2 mm past the guide) was 
attached to a 2 microliter syringe by a plastic tube. Distilled water was drawn through the 
tube until 1 microgram of distilled water could be drawn and expelled. An air bubble was 
then drawn through the tube to mark the separation between the distilled solution and the 
morphiceptin solution. Half a microliter of either 10, 500 or 1000 nanogram of 
morphiceptin in a 9% saline solution or saline was injected manually over 60 seconds into 
each side of the brain. The inner cannula was left in place for 60 seconds following the 
injection to insure that the solution diffused downward rather than returning up the 
cannula. If a discrepancy arose as to the movement of the air bubble, another dose was 
administered. Five minutes after the injection, the testing session began. 
Histological Analysis: 
Following data acquisition, all animals were anesthetized with an overdose of 
SomnotoJ. Brains were removed and 46 micron sections taken using a cryostat. Sections 
were stained using cresyl violet and the location of each cannula placement was verified. 
Data Analysis: 
Unless otherwise stated, all data were analyzed using an unweighted means­
analysis of variance (ANOVA) in a repeated measures split-plot design: Post-hoc 
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comparisons of treatment means were assessed using a modified Tukey's ratio, required 
when an unweighted-means of analysis is employed (15). 
EXPERIMENT 1: PREOPTIC INJECTIONS OF MORPHICEPTIN
 
INHIBIT MALE COPULATORY BEHAVIOR
 
Method: 
Thirty-one adult male Long Evans rats (375-450 grams) were divide.d into four 
groups. Three groups received bilateral injections of either 10, 500, or 1000 ng of 
morphiceptin/cannula in a volume of 0.5 microliter per cannula (Sigma Chemical 
Company, lot No. 84F-58352) dissolved in 0.9% saline into the MPOA. The fourth group 
was injected with saline. 
Results: 
.Of the thirty-one animals that began the study, two had both cannulae located 
outside the MPOA, four had only ona cannulae located within the MPOA, and three never 
satisfied criterion at the postoperative baseline test. That left twenty-two animals for the 
data analysis (controls, n = 7; 10 ng, n = 3; 500 ng, n = 6; 1000 ng, n = 7, (see figure 
1 for a representative placement site). As illustrated in Table 1 bilateral injections of three 
different doses of morphiceptin significantly delayed the initiation of copulatory behavior 
compared to an injection of saline alone. This was revealed by a significant main effect 
on mount and intromission latencies F (3,18) = 6.68, P < 0.01); F (3,18) = 4.57, P < 
0.01, respectively). This is also illustrated in figures 2 and 3. Post hoc analysis, however, 
9
 
revealed that morphiceptin did not increase mount and intromission latencies in a dose-
dependent manner. No other parameter was affected. For example, as can be seen in 
figure 4, morphiceptin failed to significantly alter ejaculation latencies (F = 1.26, P > O.OS). 
As illustrated in table 1, following injections of morphiceptin, 14 % (1000 ng) and 28 % 
(500 ng) of the males failed to mount or intromit. 
Bilateral injections of morphiceptin into the MPOA failed to alter significantly 
ejaculation latency (F = 1.26, P > O.OS), the PEl (F = 0.47, P > O.OS) or the mount and 
intromission frequencies (F = 1.90, P > 0.05; F = 0.23, P > 0.05, respectively) when 
compared to the saline injections (see Figure 4, and Table 1). 
EXPERIMENT 2: PRETREATMENT WITH NALOXONE BLOCKED THE 
EFFECTS OF MORPHICEPTIN INJECTIONS ON COPULATORY BEHAVIOR 
The preceding experiment demonstrated that bilateral injections of morphiceptin 
into the MPOA produced a dramatic inhibition of male copulatory behavior when 
compared to saline injected controls. In this experiment, we examined whether the 
inhibitory effects of morphiceptin on male copulatory could be blocked with pretreatment 
of a non-selective opioid antagonist (naloxone). 
Method: 
Following completion of the last behavioral test in experiment 1, all remaining 
animals were randomly divided into two groups. Group 1 received an IP injection of 
1mg/kg naloxone (lot No. 128F-0264) 20 minutes prior to bilateral injections of 1000 ng 
of morphiceptin directly into the MPOA. Group 2 was pretreated with saline. Since the 
I 
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1000 ng dose of morphiceptin produced the greatest delay in the initiation of copulation, 
we decided to examine the effects on male copulatory behavior following pretreatment 
with naloxone using bilateral injections of 1000 ng of morphiceptin into the MPOA. 
Results: 
As in Experiment 1, bilateral injections of morphiceptin increased mount and 
intromission latencies in saline pretreated animals. Pretreatment with naloxone completely 
abolished the inhibitory effects of morphiceptin (see figure 5). 
11
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DISCUSSION 
Bilateral microinjections of three different doses of morphiceptin in the MPOA 
produced a dramatic delay in the initiation of copulation in sexually vigorous male rats 
when compared to saline injected controls. This inhibition was completely abolished by 
pretreatment 20 minutes prior to morphiceptin microinjections with naloxone (1 mg/kg) 
injected IP. These results provide further support that the MPOA is an important site of 
action for the inhibitory effects of peripherally administered opioids. Moreover, these 
results strongly suggest that the delay in the initiation of copulation that is commonly 
observed following peripheral or central injections of opioids is mediated by mu receptors 
located within the MPOA. 
The results of this study partly conflict with other studies which have assessed male 
copulatory behavior following administration of non-selective opioid agonists. For 
example, no effect was observed on ejaculatory threshold following injections of 
morphiceptin (see table 1). This discrepancy can be partly explained by the 
pharmacological profile of the agonists employed in the various studies. For example, in 
the Hughes et al. study, significant increases in mount, intromission and ejaculation 
latencies were observed following bilateral injections of beta-endorphin into the MPOA 
(14). Beta-endorphin, a prototypical opioid, binds equally well to both mu and delta 
receptors. Thus, the inhibition on male sexual behavior observed in the Hughes et al. 
study may have been partially mediated via delta receptors. Indeed, pretreatment with a 
putative delta receptor antagonist (leI 174864) prevented the inhibition of male sexual 
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behavior following bilateral injections of beta-endorphin into the MPOA. Therefore, the 
results from my study taken together with Hughes' study, suggest that mu receptors 
mediate the initiation, while delta receptors may be involved in the ejaculatory threshold 
or the resolution of the copulatory sequence once copulation is initiated. 
In the literature it has been frequently reported that beta-endorphin injections 
produce a "MPOA lesion-like behavior" in male rats; that is, the male vigorously pursues 
the female but his performance halts at the point when he would normally mount her 
(14,20,21). This is not surprising based on the findings of several recent studies which 
have reported that neurochemical lesions of the MPOA in male rats lead to a dramatic 
disruption of male copulatory behavior but have no effect on operant responding for a 
sexual receptive female (10). In this type of paradigm males will bar press reliably for a 
female, but once the female is introduced, the males fail to mount or intromit. MPOA 
lesion-like behavior was repeatedly seen in this study as well. Following injections of all 
three doses of morphiceptin into the MPOA the males would almost immediately pursue 
and investigate the female anogenitally. Indeed contact latencies remained relatively low 
(means in seconds: 1000 ng = 72.0; 500 ng = 410.81; 10 ng = 18.66) following 
morphiceptin injections despite the dramatic increase in mount and intromission latencies. 
Therefore, it seems that morphiceptin like beta-endorphin injections into the MPOA does 
not interfere with the initial interest or access to the female, but interferes with an 
organization component of the motor pattern of sexual behavior. Beach (3) proposed 
that, contrary to viewing sexual behavior as a unitary construct, two separate mechanisms 
were involved in male reproductive behavior: a sexual arousal mechanism and a 
copulatory mechanism. He suggested that the arousal mechanism mediates the male's • 
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initiation of the copulatory sequence, as well as the resumption of copulation following 
ejaculation. The copulatory mechanism was assumed to maintain copulatory behavior by 
summating the excitation of each successive intromission until ejaculation occurred. 
Since its original formulation the "two factor" theory of Beach has received considerable 
attention. As a result, its conceptual framework has been continually revised. Based on 
a factor analysis of normative data on sexual behavior in male rats, Sachs (30) 
subsequently subdivided the copulatory mechanism into further dimensions, one of which 
he referred to as a "copulatory rat factor". This factor contained three components: inter­
intromission interval (which has been referred to as the ICI), ejaculation latency, and the 
post-ejaculatory interval (PEl). The reason for the inclusion of the PEl in the theoretical 
copulatory mechanism framework was to account for the relative independence of the PEl 
from mount and intromission latencies (two behavioral components associated with 
arousal). Collectively, the results of this study strongly suggest that in addition to the 
mediation of the initiation of copulation, mu receptors located within the MPOA may be 
partly involved in arousal but have no role in the copulatory mechanism of male rat sexual 
behavior. 
For example, as previously mentioned following the termination of a pursuit, the 
male would show considerable interest in the female but would not mount her. This was 
often followed by flank grooming and scratching. On other occasions, however, after an 
abortive mount, the male would lose interest in the female, sometimes for as long as 2 or 
3 minutes. 
In this study motor activity was not measured. The rationale for this is straight 
forward, there are many studies which have now been pUblished using a variety of • 
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approaches to measure motor activity following the administration of opioid agonists, 
which have concluded that at low doses, opioids inhibit male copulatory behavior without 
affecting locomotor activity (11,14,21,22,25). The findings of low contact latencies 
following morphiceptin injections further substantiate this conclusion that the disruption 
of male sexual behavior was not due to a general behavioral inhibition. 
In conclusion, the results of this study further support the importance of the opioid 
innervation of the MPOA in the regulation of male copulatory behavior. Furthermore, as 
a result of the pharmacological characterization of the specific receptor involved in the 
inhibition of male copulatory behavior, these results suggest that the initiation of copulation 
in the male rat is mediated via mu receptors and the ejaculatory threshold via another 
opioid receptor. Clearly, further research remains to be done using selective mu 
antagonists, as well as highly selective agonists before the role of different opioid 
receptors in the regulation of male copulatory behavior is clearly elucidated. Nonetheless, 
it is hoped that these results will facilitate the understanding of the role of different opioid 
receptor regulation of male rat copulatory behavior and as a result provide further insight 
into the role of endogenous opioids in the neuroregulation of male sexual behavior. 
15 
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1'1 (J r phi c: F' P tin 
Ileasures Saline 10 ng 500 ng 1000 ng 
Ill"" 
Bas!!line 7.38 ! 1.36 11. 80 ~ 5.7 69.86 :!:. 2.6 15.67:!:.7.7 
Experhental 9.96 :!:. 2.07 398.90 t 231.1 t 67.75 :!:. 152.73 t 473.80 :!:. 104.6 t 
IlF 
Baseline 6.86 :!:. 1.55 2.33 :!:. 1.30 5.50 to. 88 6.67 +.1.56 
Experilllental 8.86 :!:. 2.20 3.30 ! 1.45 5.00 ~ 2.31 5.80 t 0.98 
Il 
Baseline 18.76 :!:. 10.08 12.40 :!:.. ~. 40 21.80 ±10.94 50.38 +: 13.90 
Experilliental 59.43 :!:.. 30.60 400.70 ! 229.60 t 521.88 :!:. 166.20 • 608.12 :!:. 96.70 t 
IF 
Baseline 8.71 :!:. 1. 98 5.00 :!:.. 1. 50 7.b7 :!:.. 2.22 5.67 ±1.48 
Experimental 7.57 :!:.. 1.54 6.70 ±.2.72 5.33 ±.2.63 5.00 ±. 1. 80 
El 
Baseline 349.94 :!:.. 92.5 168.77 :!:.. 52.70 236.30 :!:. 46.60 189.90 : 39.90 
Experimen ta I 338.30 :!:. 82.94 359.10 :!:. 10.90 543.30 :!:. 135.20 297.00 ± 126.70 
leI 
Baseline 43.51 :!:.. 6.71 33.87 :!:. 3.33 27.36 +. 1.89 38.55 ±. 12.71 
Experiftlental 43.40 :!:. 4.58 80.31 ! 34.25 43.60 :!:. 8.93 31.69 ±.6.09 
PEl 
Baseline 408.43 :!:.. 28.33 392.70 :!:. 51.86 373.15 ±17.25 355.40 ±52.70 
Experhental 361. 60 :!:. 22.83 395.90 :!:. 73.60 227.50 :!:. 71. 06 447.50:!:.90.27 
XE 
Baseline 
Experimental 100 83.3 100 66.6 
"All latencies are in seconds. See text for full details. 
tp<O.Ol 
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FIGURE 1. Summarizes a representative bilateral cannula placement in males which 
received injections of either 10, 500 or 1000 ng of morphiceptin into the MPOA in 
experiments 1 and 2. Abbreviations: ac, anterior commissure; cc, corpus callosum; CPu, 
caudate putamen; GP, globus pallidus; f, fornix; ic, internal capsule; 3V, third ventricle; 
MPOA, medial preoptic area; oc, optic chiasm. 
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FIGURE 2. Comparison of the effect of morphiceptin injections to saline injections into the 
MPOA on mean mount latencies. The 10, 500 and 1000 ng doses delayed the 
occurrence of mounts significantly. Error bars in this and following figures display 
standard error on the difference between means. 
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FIGURE 3. Comparison of the effect of morphiceptin injections to saline injections into the 
MPOA on mean intromission latencies. The 10, 500 and 1000 ng doses delayed the 
occurrence of intromissions significantly. 
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FIGURE 4. Comparison of the effect of morphiceptin injections to saline injections into the 
MPOA on mean duration to ejaculation from the first intromission. None of the three 
doses significantly effected the ejaculation latency. 
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FIGURE 5. Effects of naloxone + morphiceptin (1000 ng) injections compared to saline 
+ morphiceptin (1000 ng) injections on mount, intromission and ejaculation latencies. 
Naloxone blocked the inhibitory effects of morphiceptin injections on mount and 
intromission latencies. 
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